My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Future Enterprises standalone net profit rises 615.37% in the June 2016 quarter

Sep 14,2016

Net profit of Future Enterprises rose 615.37% to Rs 315.48 crore in the quarter ended June 2016 as against Rs 44.10 crore during the previous quarter ended June 2015. Sales declined 67.64% to Rs 921.19 crore in the quarter ended June 2016 as against Rs 2846.84 crore during the previous quarter ended June 2015.

ParticularsQuarter Ended
n++Jun. 2016Jun. 2015% Var.
Sales921.192846.84-68
OPM %24.969.91-
PBDT295.07184.1360
PBT142.3249.92185
NP315.4844.10615

Powered by Capital Market - Live News

Outcome of board meeting of Sun Techno Overseas
Mar 08,2017

Sun Techno Overseas announced that the Board of Directors of the company at its meeting held on 08 March 2017 considered the following -

To appoint Rakesh Bhailalbhai Patel and Rakesh Tewari as additional directors in the board of director of the Company.

Powered by Capital Market - Live News

Indian demand will recover from 2016 lows-World Gold Council
Mar 08,2017

After a challenging 2016, Indias gold market faces headwinds. As well as the lingering effect of the policies implemented last year, the industry has more to contend with in 2017. The ban on cash transactions over Rs300,000 could hurt rural Indian demand while GST could adversely affect the industry in the short-term, said the latest report of World Gold Council.

But after falling so sharply last year, demand is unlikely to fall further. Headwinds will be off-set by strong tailwinds. A banking system flush with liquidity, the bumper crop after a good monsoon, and central government employees and pensioners inflation-busting wage hike will all support economic growth. GST will streamline Indias byzantine tax structure which, as well as boosting the economy, promises to make golds value chain more transparent. Further ahead, the economy will benefit from the groundswell of young Indians entering the workforce - a demographic dividend similar to that which underpinned the stellar growth of the Asian Tiger economies of the 1980s and 1990s. All these factors will boost Indias economic growth and support gold demand.

It is likely that the impact of demonetisation will have a behavioural impact too. The shock initiative will have tested some peoples faith in fiat currencies and reinforced their faith in gold. We conducted a large-scale piece of consumer research in Q1 2016 in which 63% of respondents in India agreed with the statement n++I trust gold more than the currencies of countriesn++. And 73% of respondents in India agreed with the statement n++gold makes me feel secure for the long-termn++. The demonetisation programme will underpin these beliefs.

Demonetisation is also boosting large jewellery retailers, and they will continue to grab a larger share of the market. Over time, consumers will move away from cash towards digital payments, and organised players should benefit from this trend. This change in market dynamics will result in more transparency and a better deal for consumers, protecting them from shady practices such as undercarating.

Indias gold demand has fallen sharply in the past, but has then recovered. Previous attempts by the authorities to clamp down on gold have failed: gold is too intimately ingrained in Indian society.

On balance, while demand is likely to improve, our view for 2017 is cautious: we expect consumers to buy between 650t and 750t. Over time, we anticipate that economic growth and greater transparency within Indias gold market will push demand higher: by 2020 we see Indian consumers buying between 850t and 950t.

Powered by Capital Market - Live News

Satin Creditcare gains as board to consider issue of shares
Mar 08,2017

The announcement was made after market hours yesterday, 7 March 2017.

Meanwhile, the S&P BSE Sensex was down 96.77 points or 0.33% at 28,902.79

On BSE, so far 23,000 shares were traded in the counter as against average daily volume of 24,856 shares in the past one quarter. The stock hit a high of Rs 396.80 and a low of Rs 384.40 so far during the day.

The stock had hit a record high of Rs 716.70 on 28 July 2016. The stock had hit a 52-week low of Rs 289.90 on 29 March 2016. The stock had underperformed the market over the past one month till 7 March 2017, sliding 14.34% compared with the Sensexs 1.97% rise. The scrip had also underperformed the market over the past one quarter, falling 0.47% as against the Sensexs 10.53% rise.

The small-cap company has equity capital of Rs 37.57 crore. Face value per share is Rs 10.

Satin Creditcare Networks net profit rose 9.53% to Rs 16.44 crore on 44.83% growth in total income to Rs 208.35 crore in Q3 December 2016 over Q3 December 2015.

Satin Creditcare Network is one of the leading microfinance companies in India.

Powered by Capital Market - Live News

GAIL (India) drops after hitting almost 2-1/2 year high
Mar 08,2017

Meanwhile, the S&P BSE Sensex was down 90.16 points, or 0.31% to 28,909.40.

Huge volumes were traded on the counter. On the BSE, 19.14 lakh shares were traded in the counter so far, compared with average daily volumes of 2.63 lakh shares in the past one quarter. The stock had hit a high of Rs 534.40 in intraday trade, its highest level since 3 November 2014. The stock had hit a low of Rs 483.90 so far during the day. The stock hit a 52-week low of Rs 332.50 on 16 March 2016.

The stock had outperformed the market over the past one month till 7 March 2017, rising 9.97% compared with 2.34% gains in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 22.55% as against Sensexs 10.53% gains.

The large-cap company has equity capital of Rs 1268.48 crore. Face value per share is Rs 10.

GAIL (India)s shareholders on 6 March 2017 passed a resolution for issuance of bonus shares. On 22 February 2017, GAIL (India) had fixed 11 March 2017, as record date for 1:3 bonus issue. On 25 January 2017, GAIL (India)s board had approved issue of one bonus share for every three shares held.

GAIL (India)s net profit rose 45.4% to Rs 982.92 crore on 9.4% decline in net sales to Rs 12107.89 crore in Q3 December 2016 over Q3 December 2015.

GAIL (India), Indias largest natural gas company, is one of the seven Maharatna Public Sector Undertakings (PSUs). Government of India held 56.11% stake in the firm as per the shareholding pattern as on 31 December 2016.

Powered by Capital Market - Live News

Adani Power drops on profit booking
Mar 08,2017

Meanwhile, the S&P BSE Sensex was down 104.03 points, or 0.36% to 28,895.3

On the BSE, 11.07 lakh shares were traded on the counter so far as against the average daily volumes of 11.97 lakh shares in the past one quarter. The stock hit a high of Rs 40.70 and a low of Rs 38.20 so far during the day.

The stock had hit a 52-week high of Rs 41.30 yesterday, 7 March 2017. The stock had hit a 52-week low of Rs 23.35 on 9 November 2016. The stock had outperformed the market over the past one month till 7 March 2017, advancing 8.46% compared with the Sensexs 1.97% rise. The scrip had also outperformed the market over the past one quarter, gaining 27.04% as against the Sensexs 10.53% rise.

The large-cap company has equity capital of Rs 3732.86 crore. Face value per share is Rs 10.

Adani Power reported consolidated net loss of Rs 323.61 crore in Q3 December 2016, compared with the net profit of Rs 109.49 crore in Q3 December 2015. Net sales declined 6.15% to Rs 5803.52 crore in Q3 December 2016 over Q3 December 2015.

Adani Power is the largest private thermal power producer in India with an installed capacity of 10,480 MW.

Powered by Capital Market - Live News

Unichem Lab advances after receiving ANDA approval from USFDA for drug
Mar 08,2017

The announcement was made during market hours today, 8 March 2017.

Meanwhile, the S&P BSE Sensex was down 117.28 points or 0.4% at 28,883.09.

More than usual volumes were witnessed on the counter. On the BSE, 14,672 shares were traded on the counter so far as against the average daily volumes of 9,367 shares in the past one quarter. The stock had hit a high of Rs 268 and a low of Rs 260.80 so far during the day. The stock had hit a 52-week high of Rs 319.90 on 20 October 2016 and a 52-week low of Rs 210.10 on 18 March 2016.

The stock had underperformed the market over the past one month till 7 March 2017, falling 4.9% compared with 2.34% gains in the Sensex. The scrip had also underperformed the market in past one quarter, gaining 0.17% as against Sensexs 10.53% gains.

The small-cap company has equity capital of Rs 18.18 crore. Face value per share is Rs 2.

Unichem Laboratories announced that it has received abbreviated new drug application (ANDA) approval from the United States Food and Drug Administration (USFDA) for Rizatriptan Benzoate ODT 5mg & 10mg and Rizatriptan Benzoate Tablets USP, 5mg & 10mg which are therapeutically equivalent to Maxalt - MLT Tablets 5mg & 10mg and Maxalt Tablets 5mg 10mg of Merck & Company, Inc.

Rizatriptan Benzoate Tablets USP, 5mg & 10mg and Rizatriptan Benzoate ODT USP, 5mg & 10mg; is a serotonin (5-HT) 1B/1D receptor agonist (triptan) indicated for the acute treatment of migraine in adults and in pediatric patients 6 to 17 years of age.

The product will be commercialized from Unichems Goa plant. Active pharmaceutical ingredient (API) will also be made in house at Roha API plant.

Unichem Laboratories net profit rose 26.3% to Rs 26.11 crore on 15.1% rise in net sales to Rs 348.79 crore in Q3 December 2016 over Q3 December 2015.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in India and several other markets across the world. In India, the company is a leader in niche therapy areas of cardiology, neurology, orthopedics and anti-infectives. The company has strong skills in product development, process chemistry and manufacturing of complex APIs as well as dosage forms.

Powered by Capital Market - Live News

Vista Pharmaceuticals to hold EGM
Mar 08,2017

Vista Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 30 March 2017 .

Powered by Capital Market - Live News

Satin Creditcare Network to hold board meeting
Mar 08,2017

Satin Creditcare Network will hold a meeting of the Board of Directors of the Company on 10 March 2017, to consider Increase in Authorized Share Capital of the Company, consider further issuance of Securities on private placement basis, to persons belonging to promoter/non promoter category, in compliance with applicable rules and regulations. and to decide about the EGM date and other requisite details.

Powered by Capital Market - Live News

Federal Bank appoints Part Time Chairman
Mar 08,2017

Federal Bank announced that RBI has accorded approval vide its letter dated 07 March 2017, for appointing K M Chandrasekhar, who is a Director on the Board of the Bank, as Part Time Chairman of the Bank for a period of one year, effective from 01 March 2017.

Powered by Capital Market - Live News

NILE fixes record date for interim dividend
Mar 08,2017

NILE has fixed 24 March 2017 as the record date for the purpose of payment of interim dividend. The Interim dividend will be paid on or before 30 March 2017.

Powered by Capital Market - Live News

Hindalco Industries announces closure of QIP issue
Mar 08,2017

Hindalco Industries announced that in respect of the QIP, the Capital Raising Committee of the Company at its meeting held on 08 March, 2017 has, inter alia, passed the following resolutions:

a. Approved the closure of the issue period for the QIP on 08 March 2017;

b. Determined and approved the Issue price of Rs. 189.45/- per Equity Share (including a premium of Rs. 188.45/- per Equity Share). [The Floor Price is Rs. 184.45/- per Equity Share determined as per the formula prescribed under Regulation 85(1) of the SEBI ICDR Regulations for the Equity Shares to be allotted to eligible qualified institutional buyers in the QIP]; and

c. Approved and adopted the placement document dated 08 March 2017, in connection with the QIP.

Powered by Capital Market - Live News

Cadila Healthcare gains after receiving final approval from USFDA for drug
Mar 08,2017

The announcement was made during market hours today, 8 March 2017.

Meanwhile, the S&P BSE Sensex was down 70.26 points or 0.24% at 28,929.30.

On the BSE, 55,640 shares were traded on the counter so far as against the average daily volumes of 1.19 lakh shares in the past one quarter. The stock had hit a high of Rs 444 and a low of Rs 436 so far during the day. The stock had hit a record high of Rs 460 on 17 February 2017. The stock had hit a 52-week low of Rs 305 on 12 April 2016.

The stock had outperformed the market over the past one month till 7 March 2017, rising 18.61% compared with 2.34% gains in the Sensex. The scrip had also outperformed the market in past one quarter, gaining 11.35% as against Sensexs 10.53% gains.

The large-cap company has equity capital of Rs 102.37 crore. Face value per share is Re 1.

Cadila Healthcare has received final approval from the United States Food & Drug Administration (USFDA) to market Tizanidine Hydrochloride Capsules, USP in strengths of 2 mg, 4 mg and 6 mg.

The drug, which is a muscle relaxant, will be produced at the special economic zone (SEZ) facility located at Ahmedabad. The estimated annual sales for Tizanidine Hydrochloride Capsules is $58.60 million as per IMS Jan 2017.

Cadila Healthcares consolidated net profit fell 34.6% to Rs 281.60 crore on 0.8% decrease in net sales to Rs 2249.60 crore in Q3 December 2016 over Q3 December 2015.

Cadila Healthcare is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.

Powered by Capital Market - Live News

Firstsource Solutions allots 750,000 equity shares
Mar 08,2017

Firstsource Solutions has allotted 750,000 Equity shares of Rs.10/- each bearing distinctive numbers 680,036,638 to 680,786,637 on March 03, 2017, under Employee Stock Option Scheme 2003 of the Company. Consequent to the said allotment, the paid up capital of the Company has increased to Rs. 6,807,866,370 consisting of 680,786,637 Equity shares of Rs.10/- each.

Powered by Capital Market - Live News

Chartered Logistics bags order worth Rs 6.3 crore
Mar 08,2017

Chartered Logistics has bagged order worth Rs 6.3 crore from GHCL to be completed in three months. Up on completion, the company expects orders worth Rs 15 crore from GHCL to be completed in 9 months.

Powered by Capital Market - Live News

Chartered Logistics bags order worth Rs 6.3 crore
Mar 08,2017

Chartered Logistics has bagged order worth Rs 6.3 crore from GHCL to be completed in three months. Up on completion, the company expects orders worth Rs 15 crore from GHCL to be completed in 9 months.

Powered by Capital Market - Live News